Medicare Enrolled

Dr. Robert Coleman, M.D.

Gynecologic Oncology Physician · Houston, TX
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
Registered in NPPES since 2006
NPI: 1669570685 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Coleman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Coleman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Coleman

Dr. Robert Coleman is a gynecologic oncology physician in Houston, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Coleman received a total of $778,350 from 54 pharmaceutical and/or device companies across 527 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Coleman is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $778,350 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$778,350
Total received (2018-2024)
Avg $111,193/year across 7 years
Top 1% in TX for gynecologic oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
527
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$195,421
2023
$90,968
2022
$117,949
2021
$114,539
2020
$104,854
2019
$103,658
2018
$50,961

Payments by company (2024)

Merck Sharp & Dohme LLC
$78,914
GlaxoSmithKline, LLC.
$27,183
ABBVIE INC.
$18,661
EMD Serono Research & Development Institute, Inc.
$18,228
BioNTech SE
$15,041
Eisai Inc.
$7,195
AstraZeneca Pharmaceuticals LP
$6,880
AstraZeneca UK Limited
$4,925
BeiGene USA, Inc.
$3,900
PFIZER INC.
$3,400
Genmab U.S., Inc.
$3,109
Aadi Bioscience, Inc.
$2,238
Karyopharm Therapeutics Inc.
$1,855
Daiichi Sankyo Inc.
$1,712
Corcept Therapeutics
$1,300
F. Hoffmann-La Roche AG
$760
ImmunoGen, Inc.
$119
Top 3 companies account for 63.8% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$117,448
GlaxoSmithKline, LLC.
$102,008
AstraZeneca UK Limited
$79,365
Merck Sharp & Dohme Corporation
$69,774
AstraZeneca Pharmaceuticals LP
$65,508
Clovis Oncology, Inc.
$50,676
Seagen Inc.
$18,931
F. Hoffmann-La Roche AG
$18,743
ABBVIE INC.
$18,661
EMD Serono Research & Development Institute, Inc.
$18,228
TESARO, Inc.
$17,428
EISAI INC.
$15,818
BioNTech SE
$15,041
Eisai Inc.
$14,472
Alkermes, Inc.
$14,419
Genentech, Inc.
$12,079
Novocure GmbH
$11,565
Chugai Pharmaceutical Co., Ltd.
$7,700
Myriad Genetic Laboratories, Inc.
$7,200
PFIZER INC.
$7,100
Novocure Inc.
$6,643
JAZZ PHARMACEUTICALS INC.
$6,000
Eisai Co., Ltd.
$5,775
Aadi Bioscience, Inc.
$5,738
Takeda Pharmaceuticals U.S.A., Inc.
$5,270
Immunocore Limited
$4,485
AbbVie, Inc.
$4,216
E.R. Squibb & Sons, L.L.C.
$4,050
BeiGene USA, Inc.
$3,900
Daiichi Sankyo Inc.
$3,744
Genentech USA, Inc.
$3,715
Seattle Genetics, Inc.
$3,665
Deciphera Pharmaceuticals Inc.
$3,600
Incyte Corporation
$3,431
Gilead Sciences, Inc.
$3,325
Janssen Products, LP
$3,194
Genmab U.S., Inc.
$3,171
Taiho Oncology, Inc.
$2,952
Bayer HealthCare Pharmaceuticals Inc.
$2,850
Novartis Pharmaceuticals Corporation
$2,638
Eli Lilly and Company
$2,625
Karyopharm Therapeutics Inc.
$2,590
ImmunoGen, Inc.
$2,181
Regeneron Pharmaceuticals, Inc.
$1,965
Epizyme, Inc.,
$1,500
Corcept Therapeutics
$1,300
Radius Health, Inc.
$656
AbbVie Inc.
$525
pharmaand GmbH
$224
Ipsen Biopharmaceuticals, Inc
$119
Ethicon US, LLC
$80
Sirtex Medical Inc
$25
Merge Healthcare Incorporated
$20
Daiichi Sankyo Company LTD
$14
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
AFINITOR · Avastin · ELAHERE · ENSEAL Product Family · Elahere · Enhertu · Entyvio · Epkinly · Fyarro · IMFINZI · KEYTRUDA · KIMMTRAK · KISQALI · Korlym · LIBTAYO · LYNPARZA · Lenvima · MK-7339 · MYCHOICE CDX · Non-Covered Product · OPDIVO · Oncology · Optune · QINLOCK · Rubraca · SIR-Spheres Microspheres · SOMATULINE DEPOT · TAZVERIK · TECENTRIQ · TIVDAK · Tecentriq · Tivdak · Venclexta · Watson Clinical Review · XPOVIO · YONDELIS · ZEJULA · ZEPZELCA · myChoice CDx
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gynecologic oncology physician in Houston?
Compare gynecologic oncology physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse gynecologic oncology physicians nearby

Geographic Context

Gynecologic oncology physicians in nearby ZIP areas
46
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Coleman is a gynecologic oncology physician, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Coleman receive payments from pharmaceutical companies?
Yes. Dr. Coleman received a total of $778,350 from 54 companies across 527 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Coleman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Gynecologic Oncology Physicians in Houston
Browse gynecologic oncology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Gynecologic Oncology Physicians in TX
Gynecologic oncology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gynecologic Oncology Physicians in TX
Which TX gynecologic oncology physicians receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →